Loading viewer...
earnings
Format: PDF earnings
Henlius reported 3Q 2023 revenue of RMB 1.4B (69% YoY growth) with net profit of RMB 168M. The biopharmaceutical company achieved key milestones including ESCC approval, strong sales from flagship products HANSIZHUANG and HANQUYOU, and strategic licensing deals for HLX10 with upfront payments totaling EUR 49M and USD 7M.
annual_report
48 Pages
earnings
57 Pages
Swiss Re
Brookfield Renewable Partners Q3 2023 Earnings Presentation
earningsearnings
28 Pages
Brookfield Renewable Partners